Dapo, Baby Boy .
HRN: 28-99-71 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2026
AMPICILLIN 250MG (VIAL)
05/15/2026
05/22/2026
IV
40mg
Q12hours
Neonatal Sepsis
Checking Initial Appropriateness
05/15/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
05/15/2026
05/22/2026
IV
4mg
Q48hours
Neonatal Sepsis
Checking Initial Appropriateness
05/26/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/26/2026
07/28/2026
IV
4MG
2X A WEEK
FUNGAL INFECTION
Checking Initial Appropriateness
05/28/2026
CEFTAZIDIME 1GM (VIAL)
05/28/2026
06/04/2026
IV
40mg
Q12
Neonatal Sepsis
Checking Initial Appropriateness
05/28/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/28/2026
06/04/2026
IV
16mg
Q36
NEONATAL SEPSIS
Checking Initial Appropriateness
05/28/2026
CEFTAZIDIME 1GM (VIAL)
05/28/2026
06/03/2026
IV
40mg
Q12
Bacterial Infection
Checking Initial Appropriateness